Skip to main content

Eagle Asset Management Inc

SEC CIK
0000790502
Latest filing
Nov 12, 2024

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Eagle Asset Management Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q3 2024 holdings

Shares (Q1 2024)
0
Sold out in Q1 2024
Value
$0
% of portfolio
0.0%
Quarters held
11
Since Q2 2021
Holdings of NTLA by Eagle Asset Management Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20240$00.0%−269,558−100.0%Sold outHolders
Q4 2023269,558$8.22M<0.1%+26,867+11.1%AddedHolders
Q3 2023242,691$7.67M<0.1%+7,462+3.2%AddedHolders
Q2 2023235,229$9.59M0.1%+63,350+36.9%AddedHolders
Q1 2023171,879$6.41M<0.1%−15,486−8.3%ReducedHolders
Q4 2022187,365$6.49M<0.1%−7,698−3.9%ReducedHolders
Q3 2022195,063$10.9M0.1%−3,969−2.0%ReducedHolders
Q2 2022199,032$10.3M0.1%−32,485−14.0%ReducedHolders
Q1 2022231,517$16.8M0.1%+10,113+4.6%AddedHolders
Q4 2021221,404$26.8M0.1%−9,908−4.3%ReducedHolders
Q3 2021231,312$31.0M0.1%−34,811−13.1%ReducedHolders
Q2 2021266,123$43.1M0.2%+266,123NewHolders